Benyam Muluneh

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Tyrosine Kinase

Chronic Myeloid Leukemia

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

The New England journal of medicine

JCO oncology practice

Pharmacy (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Melissa R Maas, Allison Yang, Michele A Muir, James B Collins, Courtney Canter, Gevorg Tamamyan, Inam Chitsike, Francine Kouya, Hoa Thi Kim Nguyen, Alia Ahmad, Ana Patricia Alcasabas, Yi-Jin Gao, Kimberly J Johnson, Gia Ferrara, Nickhill Bhakta, Benyam Muluneh
Evaluating implementation of a hospital-based cancer registry to improve childhood cancer care in low- and middle-income countries. Cancer medicine 13 (17) (2024)
James B Collins, Benyam Muluneh, Sarah E Stump
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 30 (2) (2023)
James B Collins, Benyam Muluneh, Sarah E Stump
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Benyam Muluneh, Michele A Muir, James Bernard Collins, Darrian Proco, Emily Mackler, Ashley Leak Bryant, William A Wood, Michael Tilkens, Jeffrey S Reichard, Matthew Foster, Justin Gatwood, Stephanie B Wheeler, Leah L Zullig, Jennifer Elston Lafata
Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings. PloS one 18 (7) (2023)
James B Collins, Benyam Muluneh, Sarah E Stump
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 30 (2) (2023)
James B Collins, Benyam Muluneh, Sarah E Stump
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 30 (2) (2023)
James B Collins, Benyam Muluneh, Sarah E Stump
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 30 (2) (2023)
Jessie R Signorelli, Thuy Tran, Marie E Sirek, Yarelis Díaz-Rohena, Jodi L Taraba, Benyam Muluneh, Nayanika Basu, Jennifer Lilly, Julianne Darling
Development of oral oncolytic nonadherence estimator (ORACLE): A pretreatment nonadherence risk assessment for oral oncolytics. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Rada Zunich, Megan C Roberts, Carrie M Blanchard, Benyam Muluneh, Rebecca Beth Carlson, Taylor Helms
Scoping Review to Inform the Future Development of a Measure for Team-Based Care in Oncology. JCO oncology practice (2022)
Shannon Palmer, Ashley Chen, Taylor Dennison, Cameron Czech, Jessica Auten, Kaitlyn Buhlinger, Benyam Muluneh
Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics. Pharmacy (Basel, Switzerland) 9 (3) (2021)
Benyam Muluneh
Virtues of Ruth. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Stacie B Dusetzina, Benyam Muluneh, Nancy L Keating, Haiden A Huskamp
Broken Promises - How Medicare Part D Has Failed to Deliver Savings to Older Adults. The New England journal of medicine 383 (24) (2020)
Tanner Trantham, Jessica Auten, Benyam Muluneh, Hendrik Van Deventer
Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: A cautionary tale. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (4) (2019)